Nephrolithiasis as a common urinary system manifestation of inflammatory bowel diseases; a clinical review and meta-analysis

Mahboube Ganji-Arjenaki ¹, Hamid Nasri ², Mahmoud Rafieian-Kopaei ¹ *

Cited by CrossRef: 22

1- Sălcudean A, Nan A, Bodo C, Cosma M, Strete E, Lica M. Association between Childhood Onset Inflammatory Bowel Disease and Psychiatric Comorbidities in Adulthood. Diagnostics. 2023;13(11):1868 [Crossref]

2- Scherr S, Ksiazek S, Schwarz C, Säemann M. SGLT2 Inhibitor Use for Treatment of Hypocitraturia in a Distal Renal Tubular Acidosis. Kidney Medicine. 2024;6(7):100839 [Crossref]

3- Torricelli F, Reichard C, Monga M. Urolithiasis in complicated inflammatory bowel disease: a comprehensive analysis of urine profile and stone composition. Int Urol Nephrol. 2021;53(2):205 [Crossref]

4- Zhang H, Huang Y, Zhang J, Su H, Ge C. Causal effects of inflammatory bowel diseases on the risk of kidney stone disease: a two-sample bidirectional mendelian randomization. BMC Urol. 2023;23(1) [Crossref]

5- Cunha Neto F, Marton L, de Marqui S, Lima T, Barbalho S. Curcuminoids from Curcuma Longa: New adjuvants for the treatment of crohn's disease and ulcerative colitis?. Critical Reviews in Food Science and Nutrition. 2019;59(13):2136 [Crossref]

6- Azimirad M, Tajbakhsh M, Yadegar A, Zali M. Recurrent urinary tract infection with antibiotic‐resistant Klebsiella pneumoniae in a patient with Crohn's disease: A case report. Clinical Case Reports. 2021;9(8) [Crossref]

7- SANUELLY DA PAZ MARTINS A, BOMFIM GOMES CAMPOS S, OLIVEIRA FONSECA GOULART M, OLIVEIRA FONSECA GOULART F, MOURA R. Extraintestinal manifestations of inflammatory bowel disease, nitroxidative stress and dysbiosis: What is the link between them?. 2021;45(3):461 [Crossref]

8- Alptürker K, Akgül Ö. INFLIXIMAB TREATMENT OF CROHN’S DISEASE AND SECONDARY AMYLOIDOSIS: CASE REPORT AND LITERATURE REVIEW. qrheumatol. 2023;1(4):169 [Crossref]

9- Knoedler M, Li S, Hirano S, Nakada S, Penniston K. Higher Risk of Repeat Stone Surgery in Stone Formers With Concomitant Bowel Disease: Single-Center Long-Term Analysis. Urology. 2024;188:47 [Crossref]

10- Mutalib M. Renal involvement in paediatric inflammatory bowel disease. Pediatr Nephrol. 2021;36(2):279 [Crossref]

11- Chen X, Zhang X, Li D, Qi G, Dai Y, Gu J, Chen M, Hu S, Liu Z, Yang Z. miR-155 facilitates calcium oxalate crystal-induced HK-2 cell injury via targeting PI3K associated autophagy. Experimental and Molecular Pathology. 2020;115:104450 [Crossref]

12- Koyuncu A, Cumbul A, Akyüz E, Noval M. Pomegranate seed oil mitigates liver and kidney damage in an experimental colitis model: Modulation of NF-κB activation and apoptosis. Prostaglandins & Other Lipid Mediators. 2024;171:106804 [Crossref]

13- Doumas S, Tsironis C, Bolaji A, Garantziotis P, Frangou E. Glomerulonephritis and inflammatory bowel disease: A tale of gut-kidney axis dysfunction. Autoimmunity Reviews. 2023;22(6):103327 [Crossref]

14- van Hoeve K, Hoffman I. Renal manifestations in inflammatory bowel disease: a systematic review. J Gastroenterol. 2022;57(9):619 [Crossref]

15- Zheng W, Zhou Q, Xue M, Yu X, Chen J, Ao L, Wang C. Association between inflammatory bowel disease, nephrolithiasis, tubulointerstitial nephritis, and chronic kidney disease: A propensity score‐matched analysis of US nationwide inpatient sample 2016–2018. J of Digest Diseases. 2023;24(11):572 [Crossref]

16- Zhu F, Feng D, Zhang T, Gu L, Zhu W, Guo Z, Li Y, Lu N, Gong J, Li N. Altered uric acid metabolism in isolated colonic Crohn's disease but not ulcerative colitis. J of Gastro and Hepatol. 2019;34(1):154 [Crossref]

17- Coates M, Clarke K, Williams E, Jeganathan N, Yadav S, Giampetro D, Gordin V, Smith S, Vrana K, Bobb A, Gazzio T, Tressler H, Dalessio S. Abdominal Pain in Inflammatory Bowel Disease: An Evidence-Based, Multidisciplinary Review. 2023;5(4) [Crossref]

18- Singh A, Khanna T, Mahendru D, Kahlon J, Kumar V, Sohal A, Yang J. Insights into renal and urological complications of inflammatory bowel disease. World J Nephrol. 2024;13(3) [Crossref]

19- Seo H, Seong H, Kim G, Jo Y, Cheon S, Song Y, Ryu B, Kang H, Han N. Development of Anti-inflammatory Probiotic Limosilactobacillus reuteri EFEL6901 as Kimchi Starter: in vitro and In vivo Evidence. Front Microbiol. 2021;12 [Crossref]

20- Sugihara N, Kamiya K, Kado S, Kishimoto M, Kuwahara A, Sugai J, Iwami D, Mieno M, Komine M, Ohtsuki M. Single‐center survey of incidental imaging findings on computed tomography in patients with psoriasis on biologic therapy. The Journal of Dermatology. 2023;50(8):1045 [Crossref]

21- Gajendran M, Loganathan P, Jimenez G, Catinella A, Ng N, Umapathy C, Ziade N, Hashash J. A comprehensive review and update on ulcerative colitis,. Disease-a-Month. 2019;65(12):100851 [Crossref]

22- Alameddine Z, Abi Melhem R, Dimachkie R, Rabah H, Chehab H, El Khoury M, Qaqish F, Stefanov D, El-Sayegh S. Risk of Nephrolithiasis in Patients with Inflammatory Bowel Disease Receiving Biologic Treatment. JCM. 2023;12(19):6114 [Crossref]